Bourgeon Capital Management LLC Allogene Therapeutics, Inc. Transaction History

Bourgeon Capital Management LLC

$520 Million
Q3 2024

A detailed history of Bourgeon Capital Management LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Bourgeon Capital Management LLC holds 142,580 shares of ALLO stock, worth $323,656. This represents 0.08% of its overall portfolio holdings.

Number of Shares

142,580

Previous 132,455 7.64%

Holding current value

$323,656

Previous $308,000 29.55%

% of portfolio

0.08%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$2.08 - $3.5 $21,060 - $35,437	10,125 Added 7.64%	142,580 $399,000
Q2 2024 Jul 11, 2024	BUY	$2.23 - $4.38 $167,818 - $329,616	75,255 Added 131.56%	132,455 $308,000
Q1 2024 Apr 19, 2024	BUY	$2.92 - $5.63 $18,980 - $36,595	6,500 Added 12.82%	57,200 $255,000
Q4 2023 Jan 30, 2024	SELL	$2.28 - $3.5 $25,079 - $38,500	-11,000 Reduced 17.83%	50,700 $162,000
Q3 2023 Nov 01, 2023	SELL	$3.17 - $5.96 $16,642 - $31,290	-5,250 Reduced 7.84%	61,700 $195,000
Q2 2023 Jul 20, 2023	BUY	$4.53 - $6.74 $176,670 - $262,860	39,000 Added 139.53%	66,950 $332,000
Q4 2022 Jan 20, 2023	BUY	$5.62 - $11.11 $95,540 - $188,870	17,000 Added 155.25%	27,950 $0
Q3 2022 Oct 27, 2022	SELL	$10.32 - $17.28 $217,236 - $363,744	-21,050 Reduced 65.78%	10,950 $118,000
Q2 2022 Jul 27, 2022	BUY	$6.78 - $12.28 $37,290 - $67,540	5,500 Added 20.75%	32,000 $365,000
Q1 2022 May 03, 2022	BUY	$7.65 - $15.29 $153,000 - $305,800	20,000 Added 307.69%	26,500 $241,000
Q4 2021 Jan 31, 2022	SELL	$13.13 - $24.52 $331,204 - $618,517	-25,225 Reduced 79.51%	6,500 $97,000
Q3 2021 Nov 09, 2021	SELL	$21.01 - $27.64 $33,090 - $43,533	-1,575 Reduced 4.73%	31,725 $815,000
Q2 2021 Jul 19, 2021	BUY	$23.49 - $35.8 $782,217 - $1.19 Million	33,300 New	33,300 $868,000
Q1 2021 May 13, 2021	SELL	$25.79 - $39.02 $514,510 - $778,449	-19,950 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$25.24 - $43.45 $286,474 - $493,157	11,350 Added 131.98%	19,950 $504,000
Q3 2020 Oct 28, 2020	BUY	$32.38 - $44.96 $246,088 - $341,696	7,600 Added 760.0%	8,600 $324,000
Q2 2020 Jul 27, 2020	SELL	$18.39 - $54.04 $22,987 - $67,550	-1,250 Reduced 55.56%	1,000 $43,000
Q1 2020 May 07, 2020	BUY	$18.22 - $28.25 $18,220 - $28,250	1,000 Added 80.0%	2,250 $44,000
Q4 2019 Feb 04, 2020	BUY	$24.82 - $31.4 $31,025 - $39,250	1,250 New	1,250 $32,000

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bourgeon Capital Management LLC with notifications on news.

Account

Bourgeon Capital Management LLC Allogene Therapeutics, Inc. Transaction History